To investigate whether anti-IP-10 treatment had an effect on T cell activation during malaria, we first examined the percentage of activated CD4+ and CD8+ T cells expressing CD69 and CD25 in anti-IP-10 and isotype-control-treated mice after P. berghei ANKA infection. The gene discussed is CXCL10; the disease is malaria.